論文一覧
1.Nishida T, Kubota S, Yokoi H, Mukoyama M, Takigawa M.
Roles of matricellular CCN2 deposited by osteocytes in osterclastogenesis and osteoblast differentiation.
Sci Rep. 9: 10913, 2019. Doi: 10.1038/s41598-019-47285-3.
2.Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N.
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
Hypertens Res. 42: 1235-1481, 2019. Doi: 10.1038/s41440-019-0284-9.
3.Narita Y, Hamamura K, Kashiyama M, Utsumi S, Kakizoe Y, Kondo Y, Ishitsuka Y, Jono H, Irie T, Mukoyama M, Saito H, Kadowaki D, Hirata S, Kitamura K.
Edoxaban exerts antioxidant effects through FXa inhibition and direct radical-scavenging activity.
Int Mol Sci. 20: 4140, 2019. Doi: 10.3390/ijms20174140.
4.Naruse M, Mukoyama M, Morinaga J, Miyazaki M, Iseki K, Yamagata K.
Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study.
Clin Exp Nephrol. 24: 45-52, 2019. Doi: 10.1007/s10157-019-01789-4.
5.Matsuo N, Nakayama Y, Inoue H, Izumi Y, Mukoyama M.
Successful full-term delivery in a patient with maintenance hemodialysis using natriuretic peptides as volume markers without X-ray examination: a case report and literature review.
Renal Replacement Therapy. 5: 32, 2019. Doi: https://doi.org/10.1186/s41100-019-0227-6
6.Izumi Y, Hamaguchi A, Miura R, Nakagawa T, Nakagawa M, Saida K, Miyake N, Nagayoshi Y, Kakizoe Y, Miyoshi T, Kohda Y, Misumi Y, Matsumoto N, Ando Y, Mukoyama M.
Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis.
CEN Case Rep. 9: 59-64, 2020. Doi: 10.1007/s13730-019-00429-w.
7.Morinaga J, Kakuma T, Fukami H, Hayata M, Uchimura K, Mizumoto T, Kakizoe Y, Miyoshi T, Shiraishi N, Adachi M, Izumi Y, Kuwabara T, Okadome Y, Sato M, Horiguchi H, Sugizaki T, Kadomatsu T, Miyata K, Tajiri S, Tajiri T, Tomita K, Kitamura K, Oike Y, Mukoyama M.
Circulating angiopoietin-like protein 2 levels and mortality risk in patients receiving maintenance hemodialysis: a prospective cohort study.
Nephrol Dial Transplant. 35: 854-860, 2020. Doi: 10.1093/ndt/gfz236.
8.Hata Y, Kuwabara T, Mori K, Kan Y, Sato Y, Umemoto S, Fujimoto D, Kanki T, Nishiguchi Y, Yokoi H, Kakizoe Y, Izumi Y, Yanagita M, Mukoyama M.
Ablation of myeloid cell MRP8 ameliorates nephrotoxic serum-induced glomerulonephritis by affecting macrophage characterization through intraglomerular crosstalk.
Sci Rep. 10: 3056, 2020. Doi: 10.1038/s41598-020-59970-9.
9.Yoshibayashi M, Kume S, Yasuda-Yamahara M, Yamahara K, Takeda N, Osawa N, Chin-Kanasaki M, Nakae Y, Yokoi H, Mukoyama M, Asanuma K, Maegawa H, Araki S.
Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
Biochem Biophys Res Commun. 525: 319-325, 2020. Doi: 10.1016/j.bbrc.2020.02.088.
1.Funakoshi T, Horimatsu T, Nakamura M, Shiroshita K, Suyama K, Mukoyama M,Mizukami T, Sakurada T, Baba E, Tsuruya K, Nozaki A, Yahata K, Ozaki Y, Ubara Y, Yasui H, Yoshimoto A, Fukuma S, Kondo N, Matsubara T, Matsubara K, Fukuhara S, Yanagita M, Muto M.
Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.
ESMO Open. 3: e000301, 2018. doi: 10.1136/esmoopen-2017-000301.
2.Morinaga J, Zhao J, Endo M, Kadomatsu T, Miyata K, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M, Oike Y.
Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.
PLoS One. 13(3): e0193731, 2018. doi: 10.1371/journal.pone.0193731.
3.Toda N, Mori K, Kasahara M, Koga K, Ishii A, Mori KP, Osaki K, Mukoyama M, Yanagita M, Yokoi H.
Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation.
Nephrol Dial Transplant. 33: 943-953, 2018. doi: 10.1093/ndt/gfx317.
4,Kitamura H, Nakano D, Sawanobori Y, Asaga T, Yokoi H, Yanagita M, Mukoyama M, Tokudome T, Kangawa K, Shirakami G, Nishiyama A.
Guanylyl Cyclase A in Both Renal Proximal Tubular and Vascular Endothelial Cells Protects the Kidney against Acute Injury in Rodent Experimental Endotoxemia Models.
Anesthesiology. 129(2): 296-310, 2018. doi: 10.1097/ALN.0000000000002214.
5.Miyasato Y, Yoshizawa T, Sato Y, Nakagawa T, Miyasato Y, Kakizoe Y, Kuwabara T, Adachi M, Ianni A, Braun T, Komohara Y, Mukoyama M, Yamagata K.
Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response.
Sci Rep. 8(1): 5927, 2018. doi: 10.1038/s41598-018-24257-7.
6.Komatsu H, Fujimoto S, Maruyama S, Mukoyama M, Sugiyama H, Tsuruya K, Sato H, Soma J, Yano J, Itano S, Nishino T, Sato T, Narita I, Yokoyama H.
Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR).
PLoS One. 13(5):e0196955, 2018. doi: 10.1371/journal.pone.0196955. eCollection 2018.
7.Yamaguchi E, Yoshikawa K, Nakaya I, Kato K, Miyasato Y, Nakagawa T, Kakizoe Y, Mukoyama M, Soma J.
Liddle's-like syndrome associated with nephrotic syndrome secondary to membranous nephropathy: the first case report.
BMC Nephrol. 19(1): 122, 2018: doi: 10.1186/s12882-018-0916-3.
8.Toda N, Mukoyama M, Yanagita M, Yokoi H.
CTGF in kidney fibrosis and glomerulonephritis.
Inflamm Regen. 38: 14, 2018. doi: 10.1186/s41232-018-0070-0.
9.Nakagawa T, Kakizoe Y, Iwata Y, Miyasato Y, Mizumoto T, Adachi M, Izumi Y, Kuwabara T, Suenaga N, Narita Y, Jono H, Saito H, Kitamura K, Mukoyama M.
Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.
Am J Physiol Renal Physiol. 315(5): F1347-F1357, 2018. doi: 10.1152/ajprenal.00648.2017.
10.Makino Y, Hikita H, Kodama T, Shigekawa M, Yamada R, Sakamori R, Eguchi H, Morii E, Yokoi H, Mukoyama M, Hiroshi S, Tatsumi T, Takehara T.
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Cancer Res. 78(17): 4902-4914, 2018. doi: 10.1158/0008-5472.CAN-17-3844.
11.Yasuoka Y, Izumi Y, Nagai T, Fukuyama T, Nakayama Y, Inoue H, Horikawa K, Kimura M, Nanami M, Yanagita K, Oshima T, Yamazaki T, Uematsu T, Yamamura R, Kobayashi N, Shimada Y, Nagaba Y, Nakanishi T, Yamashita T, Mukoyama M, Sato Y, Kawahara K, Nonoguchi H.
Fludrocortisone stimulates erythropoietin production in the intercalated cells of the collecting ducts.
Biochem Biophys Res Commun. 503: 3121-3127, 2018; doi: 10.1016/j.bbrc.2018.08.102.
12.Eguchi K, Izumi Y, Nakayama Y, Inoue H, Marume T, Matsuo N, Hiramatsu A, Ono M, Kakizoe Y, Kuwabara T, Nonoguchi H, Mukoyama M.
Insufficiency of urinary acid excretion of overweight or obese patients with chronic kidney disease and its involvement with renal tubular injury.
Nephrology (Carlton). 24 (11): 1131-1141, 2018. doi: 10.1111/nep.13553.
13.Yoshimura Y, Taguchi A, Tanigawa S, Yatsuda J, Kamba T, Takahashi S, Kurihara H, Mukoyama M, Nishinakamura R.
Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells.
J Am Soc Nephrol. 30: 304-321, 2019. doi: 10.1681/ASN.2018070747.
14.Okamura K, Kuwabara T, Enoki H, Kohda Y, Adachi M, Hayashida S, Inomata Y, Mukoyama M.
Regression of hepatitis C virus-associated membranoproliferative glomerulonephritis with direct-acting antiviral therapy after liver transplantation.
Nephrology (Carlton). 24(11): 1198-1199, 2019. doi: 10.1111/nep.13492.
1.Izumi Y, Inoue H, Nakayama Y, Eguchi K, Yasuoka Y, Matsuo N, Nonoguchi H, Kakizoe Y,Kuwabara T, Mukoyama M
TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct.
PLoS One 12 (8): e0184185, 2017; doi: 10.1371/journal.pone.0184185.
3.Guan Y, Nakano D, Zhang Y, Li L, Liu W, Nishida M, Kuwabara T, Morishita A, Hitomi H,Mori K, Mukoyama M, Masaki T, Hirano K, Nishiyama A
A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy.
J Pharmacol Sci 135 (2): 81-88, 2017.
4.Kanai Y, Yasoda A, Mori KP, Watanabe-Takano H, Nagai-Okatani C, Yamashita Y, Hirota K,Ueda Y, Yamauchi I, Kondo E, Yamanaka S, Sakane Y, Nakao K, Fujii T, Yokoi H, Minamino N, Mukoyama M, Mochizuki N, Inagaki N
Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.
J Clin Invest 127 (11): 4136-4147, 2017.
5.Ishii A, Katsuura G, Imamaki H, Kimura H, Mori KP, Kuwabara T, Kasahara M, Yokoi H, Ohinata K, Kawanishi T, Tsuchida J, Nakamoto Y, Nakao K, Yanagita M, Mukoyama M, Mori K
Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice.
Sci Rep 7 (1): 15501, 2017; doi: 10.1038/s41598-017-15825-4.
6.Hayata M, Yamashita J, Tokunaga M. Ejima M, Sagishima K, Nakagawa S, Hashimoto D,
Baba H, Maruyama K, Kohrogi Y, Mizumoto T, Mukoyama M, Kamohara H
Refractoryperitonitis by spontaneous perforation of the common bile duct in a patient receiving peritoneal dialysis.
Renal Replacement Therapy 3: 53, 2017; doi: 10.1186/s41100-017-0132-9.
7.Funakoshi T, Horimatsu T, Nakamura M, Shiroshita K, Suyama K, Mukoyama M, Mizukami T, Sakurada T, Baba E, Tsuruya K, Nozaki A, Yahata K, Ozaki Y, Ubara Y, Yasui H, Yoshimoto A, Fukuma S, Kondo N, Matsubara T, Matsubara K, Fukuhara S, Yanagita M, Muto M
Chemotherapy in cancer patients undergoing hemodialysis: A nationwide study in Japan.
ESMO Open 3 (2): e000301, 2018; doi: 10.1136/esmoopen-2017-000301.
8.Morinaga J, Zhao J, Endo M, Kadomatsu T, Miyata K, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M, Oike Y
Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.
PLoS One 13 (3): e0193731, 2018; doi: 10.1371/journal.pone.0193731.
9.Miyasato Y, Yoshizawa T, Sato Y, Nakagawa T, Miyasato Y, Kakizoe Y, Kuwabara T, Adachi M, Ianni A, Braun T, Komohara Y, Mukoyama M, Yamagata K
Sirtuin 7 deficiency ameliorates cisplatin-induced acute kidney injury though regulation of the inflammatory response.
Sci Rep 8 (1): 5927, 2018; doi: 10.1038/s41598-018-24257-7.
1.Kato Y, Mori K, Kasahara M, Osaki K, Ishii A, Mori KP, Toda N, Ohno S, Kuwabara T, Tokudome T, Kishimoto I, Saleem MA, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H
Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition.
Sci Rep 7: in press, 2017.
2.Ono S, Kume S, Yasuda-Yamahara M, Yamahara K, Takeda N, Chin-Kanasaki M, Araki H, Sekine O, Yokoi H, Mukoyama M, Uzu T, Araki S, Maegawa H
O-linked-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
Nephrol Dial Transplant 32: published on line, Feb. 27, 2017; doi: 10.1093/ndt/gfw463.
3.Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K
Increase of total nephron albumin filtration and reabsorption in diabetic nephropathy.
J Am Soc Nephrol 28 (1): 278-289, 2017.
4.Toda N, Yokoi H, Mori K, Mukoyama M
Production and analysis of conditional KO mice of CCN2 in kidney.
Methods Mol Biol 1489: 377-390, 2017.
5.Yokoi H, Mukoyama M
Analysis of pathological activities of CCN proteins in fibrotic disease: Kidney Fibrosis.
Methods Mol Biol 1489: 431-443, 2017.
6.Toda N, Mori K, Kasahara M, Ishii A, Koga K, Ohno S, Mori KP, Kato Y, Osaki K, Kuwabara T, Kojima K, Taura D, Sone M, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H
Crucial role of mesangial cell-derived connective tissue growth factor in a mouse model anti-glomerular basement membrane glomerulonephritis.
Sci Rep 7: 42114, 2017.
7.Kakizoe Y, Miyasato Y, Onoue T, Nakagawa T, Hayata M, Uchimura K, Morinaga J, Mizumoto T, Adachi M, Miyoshi T, Sakai Y, Tomita K, Mukoyama M, Kitamura K
A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity.
J Pharmacol Sci 132 (2): 145-153, 2016.
8.Ohno S, Yokoi H, Mori K, Kasahara M, Kuwahara K, Fujikura J, Naito M, Kuwabara T, Imamaki H, Ishii A, Saleem MA, Numata T, Mori Y, Nakao K, Yanagita M, Mukoyama M
Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure.
Sci Rep 6: 27192, 2016.
9.Sharmin S, Taguchi A, Kaku Y, Yoshimura Y, Ohmori T, Sakuma T, Mukoyama M, Yamamoto T, Kurihara H, Nishinakamura R
Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation.
J Am Soc Nephrol 27 (6): 1778-1791, 2016.
10.Iwashita Y, Kuwabara T, Hayata M, Kakizoe Y, Izumi Y, Iiyama J, Kitamura K, Mukoyama M
Mild systemic thermal therapy ameliorates renal dysfunction in a rodent model of chronic kidney disease.
Am J Physiol Renal Physiol 310 (11): F1206-F1215, 2016.
11.DuMond JF, Ramkissoon K, Zhang X, Izumi Y, Wang X, Eguchi K, Gao S, Mukoyama M, Burg MB, Ferraris JD
Peptide affinity analysis of proteins that bind to an unstructured N-terminal region of the osmoprotective transcription factor NFAT5.
Physiol Genomics 48 (4): 290-305, 2016.
12.Yoshimura Y, Kuwabara T, Shiraishi N, Kakizoe Y, Tasaki M, Obayashi K, Ando Y, Mukoyama M
Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup.
Nephrology 21 (4): 341-342, 2016.
1. Nakano D, Doi K, Kitamura H, Kuwabara T, Mori K, Mukoyama M, Nishiyama A.
Reduction of tubular flow rate as a mechanism of oliguria in the early phase of endotoxemia revealed by intravital imaging.
J Am Soc Nephrol 26: 3035-3044, 2015.
2. Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K.
Increased bone turnover and possible accelerated fracture healing in a murine model with an increased circulating C- type natriuretic peptide.
Endocrinology 156: 2518-2529, 2015.
3. Izumi Y, Yang W, Zhu J, Burg MB, Ferraris JD.
RNA-Seq analysis of high Nacl-induced gene expression.
Physiol Genomics 47: 500-513, 2015.
4. Koga K, Yokoi H, Mori K, Kasahara M, Kuwabara T, Imamaki H, Ishii A, Mori KP, Kato Y, Ohno S, Toda N, Saleem MA, Sugawara A, Nakao K, Yanagita M, Mukoyama M.
MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Diabetologia 58: 2169-2180, 2015.
5. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M, Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
Low serum neutrophil gelatinase-associated lipocalin level as a marker of malnutrition in maintenance hemodialysis patients.
PloS One 10: e0132539, 2015.
6. Izumi Y, Nakayama Y, Onoue T, Inoue H, Mukoyama M.
Renal tubular acidosis complicated with hyponatremia due to cortisol insufficiency.
Oxd Med Case Reports 19: 360-363, 2015.
7. DuMond JF, Ramkissoon K, Zhang X, Izumi Y, Wang X, Eguchi K, Gao S, Mukoyama M, Burg MB, Ferraris JD.
Peptide affinity analysis of proteins that bind to an unstructured NH2-terminal region of the osmoprotective transcription factor NFAT5.
Physiol Genomics 48: 290-305, 2016.
8. Miyasato Y, Miyoshi T, Fujimoto D, Adachi M, Kitamura K, Mukoyama M.
Successful treatment of rapidly progressive immunoglobulin A nephropathy with human immunodeficiency virus infection by steroid pulse therapy and tonsillectomy.
Nephrology 21: 159-160, 2015.
9. Morinaga J, Kadomatsu T, Miyata K, Endo M, Terada K, Tian Z, Sugizaki T, Tanigawa H, Zhao J, Zhu S, Sato M, Araki K, Iyama K, Tomita K, Mukoyama M, Kitamura K, Oike Y.
Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.
Kidney Int 89: 327-341, 2016.
10. Narita Y, Ueda M, Uchimura K, Kakizoe Y, Miyasato Y, Mizumoto T, Morinaga J, Hayata M, Nakagawa T, Adachi M, Miyoshi T, Sakai Y, Kadowaki D, Hirata S, Mukoyama M, Kitamura K.
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
J Pharmacol Sci 130: 110-116, 2016.
11. Yoshimura Y, Kuwabara T, Shiraishi N, Kakizoe Y, Tasaki M, Obayashi K, Ando Y, Mukoyama M.
Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup.
Nephrology 21: 341-342, 2016.
1. Izumi Y, Kawahara K, Nonoguchi H.
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy.
N Engl J Med. 370(8):777-8, 2014.
2. Izumi Y, Burg MB, Ferraris JD.
14-3-3-β and -ε contribute to activation of the osmoprotective transcription factor NFAT5 by increasing its protein abundance and its transactivating activity.
Physiol Rep 2: e12000, 2014.
3. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Nakao K.
Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
Clin Exp Nephrol 18: 584-592, 2014.
4. Kasahara T, Nakagawa T, Yokoi H, Kuwabara T, Yasuno S, Mori K, Mukoyama M, Ueshima K.
Do statins play a role in renoprotection?
Clin Exp Nephrol 18: 282-285, 2014.
5. Uetake R, Sakurai T, KamiyoshiA, Ichikawa-Shindo Y, Kawate H, Iesato Y, Yoshizawa T, Koyama T, Yang L, Toriyama Y, Yamauchi A, Igarashi K, Tanaka M, Kuwabara T, Mori K, Yanagita M, Mukoyama M, Shindo T.
Adrenomedullin- RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection.
PLoS One 9: e87667, 2014.
6. Kuwabara T, Mori K, Kasahara M, Yokoi H, Imamaki H, Ishii A, Koga K, Sugawara A, Yasuno S, Ueshima K, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Nakao K, Mukoyama M.
Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.
PLoS One 9: e88942, 2014.
7. Itoh K, Izumi Y, Inoue T, Inoue H, Nakayama Y, Uematsu T, Fukuyama T, Yamazaki T, Yasuoka Y, Makino T, Nagaba Y, Tomita K, Kobayashi N, Kawahara K, Mukoyama M, Nonoguchi H.
Expression of three isoforms of Na-K-2Cl cotransporter (NKCC2) in the kidney and regulation by dehydration.
Biochem Biophys Res Commun 453: 356-361, 2014.
8. Mukoyama M, Nakayama Y, Adachi M.
Renal angioplasty for atherosclerotic renal artery stenosis revisited – efficacy and safety of renal artery stenting in the J-RAS study.
Circ J 79: 295-296, 2015.
9. Kanda J, Mori K, Kawabata H, Kuwabara T, Mori KP, Imamaki H, Kasahara M, Yokoi H, Mizumoto C, Thoennissen NH, Koeffler HP, Barasch J, Takaori-Kondo A, Mukoyama M, Nakao K.
An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.
Clin Exp Nephrol 19: 99-106, 2015.
10. Shiraishi N, Kitamura K, Hayata M, Ogata T, Tajiri-Okamura K, Nakayama Y, Kohda Y, Tomita K, Mukoyama M.
Low-density lipoprotein apheresis for proteinuria in lupus nephritis with intraglomerular foam cells containing cholesterol crystals.
Am J Kidney Dis 65: 490-493, 2015.
11. Ueda M, Uchimura K, Narita Y, Miyasato Y, Mizumoto T, Morinaga J, Hayata M, Kakizoe Y, Adachi M, Miyoshi T, Shiraishi N, Kadowaki D, Sakai Y, Mukoyama M, Kitamura K.
The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.
Nephron 129: 223-232, 2015.
Hayata M, Kakizoe Y, Uchimura K, Morinaga J, Yamazoe R, Mizumoto T, Onoue T, Ueda M, Shiraishi N, Adachi M, Miyoshi T, Sakai Y, Tomita K, Kitamura K.
Effect of a serine protease inhibitor on the progression of chronic renal failure.
Am J Physiol Renal Physiol., Oct 15;303(8):F1126-35.2012
Uchimura K, Kakizoe Y, Onoue T, Hayata M, Morinaga J, Yamazoe R, Ueda M, Mizumoto T, Adachi M, Miyoshi T, Shiraishi N, Sakai Y, Tomita K, Kitamura K.
In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats.
Am J Physiol Renal Physiol., Oct;303(7):F939-43.2012
Kitamura, K., and Tomita, K.
Proteolytic activation of ENaC and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension
Clin. Exp. Nephrol., in press, 2011
Adachi, M., Miyoshi, T., Shiraishi, N., Shimada, H., Sakaguchi, S., Tomita, K., and Kitamura, K.
A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism
Clin. Nephrol., 76: 266-272, 2011
Anraku, M., Takeuchi, K., Watanabe, H., Kadowaki, D., Kitamura, K., Tomita, K., Kuniyasu, A., Suenaga, A., Maruyama, T., and Otagiri, M.
Cys34 on antioxidative propertie of HSA quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients
J. Pharm. Sci., in press, 2011
Shiraishi, N., Kitamura, K., Hayata, M., Ogata, T., Adachi, M., Kajiwara, K., Ikeda, H., Miyoshi, T., and Tomita, K.
A case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy
Intern. Med. J., in press, 2011
Izumi, Y., Hori, K., Nakayama, Y., Kimura, M., Hasuike, Y., Nanami, M., Kohda, Y., Otaki, Y., Kuragano, T., Obinata, M., Kawahar,a K., Tanoue, A., Tomita, K., Nakanishi, T., and Nonoguchi, H.
Aldosterone requires vasopressin v1a receptors on intercalated cells to mediate acid-base homeostasis
J. Am. Soc. Nephrol., 22: 673-680, 2011
Kitamura, K. and Tomita, K.
Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors
Clin. Exp. Nephrol., 14: 405-410, 2010
Chai, K., Kitamura, K., McCann, A., and Wu, X.-R.
The Epithelium-Molecular Landscaping for an Interactive Barrier
J. Biomed. Biotech., 2010: 870506, 2010
Ko, T., Kakizoe, Y., Wakida, N., Hayata, M., Uchimura, K., Shiraishi, N., Miyoshi, T., Adachi, M., Aritomi, S., Konda, T., Tomita, K., and Kitamura, K.
Regulation of adrenal aldosterone production by serine protease prostasin
J. Biomed. Biotech., 2010: 793843, 2010
Jutabha, P., Anzai, N., Kitamura, K., Taniguchi, A., Kaneko, S., Yan, K., Yamada, H., Shimada, H., Kimura, T., Katada, T., Fukutomi, T., Tomita, K., Urano, W., Yamanaka. H., Seki, G., Fujita, T., Moriyama, Y., Yamada, A., Uchida, S., Wempe, M. F., Endou, H.,and Sakurai, H.
Human sodium-phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate
J. Biol. Chem., 285: 35123-35132, 2010
Sugahara, T., Koga, T., Ueno-Shuto, K., Shuto, T., Watanabe, E., Maekawa, A., Kitamura, K., Tomita, K., Mizuno, A., Sato, T., Suico, M. A., and Kai. H.
Calreticulin positively regulates the expression and function of epithelial sodium channel
Exp. Cell Res., 315: 3294-3300, 2009
Kakizoe, Y., Kitamura, K., Wakida, N., Ko, T., Maekawa, A., Miyoshi, T., Shiraishi, N., Adachi, M., Zhang, Z., Masilamani, S. and Kimio Tomita
Aberrant ENaC activation in Dahl salt-sensitive rats
J. Hypertens., 27: 1679-1689, 2009
Koda, A., Wakida, N., Toriyama, K., Yamamoto, K., Iijima, H., Tomita, K., and Kitamura, K.
Urinary prostasin in humans: relationships among prostasin, aldosterone and epithelial sodium channel activity
Hypertens. Res., 32: 267-281, 2009
Maekawa, A., Kakizoe, Y., Miyoshi, T., Wakida, N., Ko, T., Shiraishi, N., Adachi, M., Tomita, K., and Kitamura, K.
Camostat mesilate inhibits prostasin activity, and reduces blood pressure and renal injury in salt-sensitive hypertension
J. Hypertens., 27: 181-189, 2009
Nonoguchi, H., Kohda, Y., Fukutomi, R., Nakayama, Y., Naruse, M., Kitamura, K., Inoue, T., Nakanishi, T., and Tomita, K.
A case with acute renal failure and subsequent nephrotic syndrome
Ren. Fail., 31: 162-166, 2009
Memetimin, H., Izumi, Y., Nakayama, Y., Kohda, Y., Inoue, H., Nonoguchi, H., and Tomita, K.
Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation
Am. J. Physiol. Renal. Physiol., 297: F620-F628, 2009
Miyakawa, K., Tarao, K., Ohshige, K., Morinaga, S., Ohkawa, S., Okamoto, N., Shibuya, A., Adachi, S., Miura, Y., Fujiyama, S., Miyase, S., and Tomita, K.
High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis
Scand. J. Gastroenterol., 44: 1340-1348, 2009
Nakayama, Y., Nonoguchi, H., Kohda, Y., Inoue, H., Memetimin, H., Izumi, Y., and Tomita, K.
Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms
Nephron. Clin. Pract., 111: c240-246, 2009
Wakamatsu, S., Nonoguchi, H., Ikebe, M., Machida, K., Izumi, Y., Memetimin, H., Nakayama, Y., Nakanishi, T., Kohda, Y., and Tomita, K.
Vasopressin and hyperosmolality regulate NKCC1 expression in rat OMCD
Hypertens. Res., 32: 481-487, 2009
Matsuo, S., Imai, E., Horio, M., Yasuda, Y., Tomita, K., Nitta, K., Yamagata, K., Tomino, Y., Yokoyama, H., and Hishida, A.
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Am. J. Kidney. Dis., 53: 982-992, 2009
Mouri, T., Inoue, T., Nonoguchi, H., Nakayama, Y., Miyazaki, H., Matsuzaki, T., Saito, H., Nakanishi, T., Kohda, Y., and Tomita, K
Acute and chronic metabolic acidosis interferes with aquaporin-2 translocation in the rat kidney collecting ducts
Hypertens. Res., 32: 358-363, 2009
Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. Clin Biochem. 41(14-15):1168-74. 2008
Anzai, N., Ichida, K., Jutabha, P., Kimura, T., Babu, E., Jin, C.J., Srivastava, S., Kitamura, K., Hisatome, I., Endou, H., and Sakurai, H.
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
J. Biol. Chem., 283: 26834-26838, 2008
Iwao, Y., Nakajou, K., Nagai, R., Kitamura, K., Anraku, M., Maruyama, T., and Otagiri, M.
CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products
Am. J. Physiol. (Renal Physiol.), 295: F1871-F1880, 2008
Nonoguchi, H., Kiyama, S., Kitamura, K., Naruse, M., Tomita, M., Tazoe, N., Tajiri, M., Nakayama, Y., Kohda, Y., Inoue, T., and Tomita, K.
Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure
Hypertens. Res., 31: 29-36, 2008
Nonoguchi, H., Izumi, Y., Nakayama, Y., Kohda, Y., and Tomita., K.
The MAXIMA trial
Lancet, 371: 299-300, 2008
Izumi, Y., Nakayama, Y., Memetimin, H., Inoue, T., Kohda, Y., Nonoguchi, H., and Tomita, K.
Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction
Am. J. Physiol. Renal. Physiol., 295: F1170-F1176, 2008
Nakayama, Y., Inoue, T., Kohda, Y., Inoue, H., Izumi, Y., Tomita, K., and Nonoguchi, H.
Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease
Clin. Nephrol., 69: 402-407, 2008
Aoyagi, T., Izumi, Y., Hiroyama, M., Matsuzaki, T., Yasuoka, Y., Sanbe, A., Miyazaki, H., Fujiwara, Y., Nakayama, Y., Kohda, Y., Yamauchi, J., Inoue, T., Kawahara, K., Saito, H., Tomita, K., Nonoguchi, H., and Tanoue, A.
Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells
Am. J. Physiol. Renal. Physiol., 295: F100-F107, 2008
Yokoyama, H., Anzai, N., Ljubojevic, M., Ohtsu, N., Sakata, T., Miyazaki, H., Nonoguchi, H., Islam, R., Onozato, M., Tojo, A., Tomita, K., Kanai, Y., Igarashi, T., Sabolic, I., and Endou, H.
Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct
Cell. Physiol. Biochem., 21: 269-278, 2008
Matsuzaki, T., Morisaki, T., Sugimoto, W., Yokoo, K., Sato, D., Nonoguchi, H., Tomita, K., Terada, T., Inui, K., Hamada, A., and Saito, H.
Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury
Drug. Metab. Dispos., 36: 649-654, 2008
Shimoishi, K., Anraku, M., Kitamura, K., Tasaki, Y., Taguchi, K., Hashimoto, M., Fukunaga, E., Maruyama, T., and Otagiri, M.
An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure
Pharm. Res., 24: 1283-1289, 2007
Kadowaki, D., Anraku, M., Tasaki, Y., Kitamura, K., Wakamatsu, S., Tomita, K., Gebicki, J. M., Maruyama, T., and Otagiri, M.
Effect of Olmesartan on Oxidative Stress in Hemodialysis Patients
Hypertens. Res., 30: 395-402, 2007
Nonoguchi, H., Nakayama, Y., Shiigai, T., Inoue, T., Inoue, H., Kohda, Y., Honda, Y., and Tomita, K.
Low-responders to angiotensin II receptor blockers and genetic polymorphism in angiotensin-converting enzyme
Clin. Nephrol., 68: 209-215, 2007
Matsuzaki, T., Watanabe, H., Yoshitome, K., Morisaki, T., Hamada, A., Nonoguchi, H., Kohda, Y., Tomita, K., Inui, K., and Saito, H.
Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure
Kidney. Int., 71: 539-547, 2007
Izumi, Y., Nakayama, Y., Mori, T., Miyazaki, H., Inoue, H., Kohda, Y., Inoue, T., Nonoguchi, H., and Tomita, K.
Down-regulation of vasopressin V2 receptor promoter activity via V1a receptor pathway
Am. J. Physiol. Renal. Physiol., 292: F1418-F1226, 2007
Machida, K., Wakamatsu, S., Izumi, Y., Yosifovska, T., Matsuzaki, T., Nakayama, Y., Kohda, Y., Inoue, T., Saito, H., Tomita, K., and Nonoguchi, H.
Down-regulation of V2 Vasopressin Receptor in Dehydration: Mechanisms and the Role of Renal Prostaglandin Synthesis
Am. J. Physiol. Renal. Physiol., 292: F1274-F1282, 2007
Naruse, M., Sakaguchi, S., Nakayama, Y., Nonoguchi, H., and Tomita, K.
A novel method for dry weight assessment in hemodialysis patients: utilization of inferior vena cava flat ratio to correct for individual variations in vessel diameter
Ther. Apher. Dial., 11: 42-48, 2007
Nonoguchi, H., Nakayama, Y., Inoue, T., Kohda, Y., and Tomita, K.
Target haemoglobin concentrations in chronic kidney disease
Lancet., 359: 1517, 2007
Wakida, N., Kitamura, K., Tuyen, D.G., Maekawa, A., Miyoshi, T., Adachi, M., Shiraishi, N., Ko, T., Ha, V., Nonoguchi, H., and Tomita, K.
Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-β1 and aldosterone
Kidney Int., 70: 1432-1438, 2006
Shiraishi, N., Kitamura, K., Miyoshi, T., Adachi, M., Nonoguchi, H., Misumi, S., Maekawa, Y., Murayama, T., Tomita, M., and Tomita, K.
Successful treatment in a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium
Am. J. Kidney Dis., 48: 151-154, 2006
Kitamura, K. and Tomita, K.
Familial pseudohyperkalemia: a rare syndrome, but diverse genetic heterogeneity
Intern. Med., 44: 781-782, 2005
Nagano, J., Kitamura, K., Hujer, K.M., Ward, C.J., Bram, R.J., Hopfer, U., Tomita, K., Huang, C., and Miller, R.T.
Fibrocystin Interacts with CAML, A Protein Involved in Ca2+ Signaling
Biochem. Biophys. Res. Commun., 338: 880-889, 2005
Kitamura, K., Shimada, H., Anraku, M., Miyoshi, T., Adachi, M., Tuyen, D.G., Wakamatsu, S., Nonoguchi, H., Tanaka, M., and Tomita, K.
Effect of telmisartan on ABPM, plasma BNP, and oxidative status of serum albumin in hemodialysis patients
Hypertens. Res., 28: 987-994, 2005
Mera, K., Anraku, M., Kitamura, K., Nakajou, K., Maruyama, T., Tomita, K., and Otagiri, M.
Oxidation and Carboxyl methyl lysine (CML)-modification of albumin; Possible involvement in the progression of oxidative stress in hemodialysis patients
Hypertens. Res., 28: 973-980, 2005
Mera, K., Anraku, M., Kitamura, K., Nakajou, K., Maruyama, T., and Otagiri, M.
The structure and function of oxidized albumin in hemodialysis patients; its role in elevated oxidative stress via neutrophil burst
Biochem. Biophys. Res. Commun., 334: 1322-1328, 2005
Wakida, N., Tuyen, D.G., Adachi, M., Miyoshi, T., Nonoguchi, H., Oka, T., Ueda, O., Tazawa, M., Kurihara, S., Yoneta, Y., Shimada, H., Oda, T., Kikuchi, Y., Matsuo, H., Hosoyamada, M., Endou, H., Otagiri, M., Tomita, K., and Kitamura, K.
Mutations in hURAT1 gene in pre-secretory reabsorption defect type of familial renal hypouricemia
J. Clin. Endocr. Metab., 90: 2169-2174, 2005
Furuhashi, M., Kitamura, K., Adachi, M., Miyoshi, T., Wakita, N., Ura, N., Shikano, Y., Shinshi, Y., Sakamoto, K., Hayashi, M., Satoh, N., Nishitani, T., Tomita, K., Shimamoto, K.
Liddle’s syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel β subunit
J. Clin. Endocr. Metab., 90: 340-344, 2005
Tuyen, D.G., Kitamura, K., Adachi, M., Miyoshi, T., Wakida, N., Nagano, J., Nonoguchi, H., and Tomita, K.
Inhibition of prostasin expression by TGF-β1 in renal epithelial cells
Kidney. Int., 67: 193-200, 2005
Anzai, N., Jutabha, P., Enomoto, A., Yokoyama, H., Nonoguchi, H., Hirata, T., Shiraya, K., He, X., Cha, SH., Takeda, M., Miyazaki, H., Sakata, T., Tomita, K., Igarashi, T., Kanai, Y., and Endou, H.
Functional Characterization of Rat Organic Anion Transporter 5 (Slc22a19) at the Apical Membrane of Renal Proximal Tubules
J. Pharmacol. Exp. Ther., 315: 534-544, 2005
Sakuma, Y., Nonoguchi, H., Takayama, M., Yang, T., Terada, Y., Inoue, T., Nakayama, Y., Kohda, Y., Sasaki, S., and Tomita, K.
Differential effects of hyperosmolality on Na-K-ATPase and vasopressin-dependent camp generation in the medullary thick ascending limb and outer medullary collecting duct
Hypertens. Res., 28: 671-679, 2005
Tanaka, M., Ohashi, T., Kobayashi, M., Eto, Y., Miyamura, N., Nishida, K., Araki, E., Itoh, K., Matsushita, K., Hara, M., Kuwahara, K., Nakano, T., Yasumoto, N., Nonoguchi, H., and Tomita, K.
Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients
Clin. Nephrol., 64: 281-287, 2005
Nakayama, Y., Nonoguchi, H., Kiyama, S., Kohda, Y., Inoue, T., and Tomita, K.
Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure
Hypertens. Res., 28:733-739, 2005
Miyazaki, H., Anzai, N., Ekaratanawong, S., Sakata, T., Shin, HJ., Jutabha, P., Hirata, T., He, X., Nonoguchi, H., Tomita, K., Kanai, Y., and Endou, H.
Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins
J. Am. Soc. Nephrol., 16: 3498-3506, 2005
Miyase, S., Tateishi, S., Watanabe, K., Tomita, K., Suzuki, K., Inoue, H., and Yamaizumi, M.
Differential regulation of Rad18 through Rad6-dependent mono-and polyubiquitination
J. Biol. Chem., 280: 515-524, 2005
Inoue, H., Kozlowski, S.D., Klein, J.D., Bailey, J.L., Sands, J.M., and Bagnasco, S.M.
Regulated expression of renal and intestinal UT-B urea transporter in response to varying urea load.
Am. J. Physiol. Renal. Physiol., 289: F451-458, 2005
Anraku M, Kitamura K, Shinohara A, Adachi M, Suenga A, Maruyama T, Miyanaka K, Miyoshi T, Shiraishi N, Nonoguchi H, Otagiri M, Tomita K. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int. 66(2):841-8. 2004
Ikeda, M., Maeda, S., Shibata, J., Muta, R., Ashihara, H., Tanaka, M., Fujiyama, S., and Tomita, K.
Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma
Oncology., 66: 24-31, 2004
Baba, T., Nonoguchi, H., Itoh, K., Nakayama, Y., Kohda, Y., Inoue, T., and Tomita K.
Gene regulation of renal-osmotic stress-induced Na-Cl organic solute cotransporter
Nephron. Exp. Nephrol., 96: E89-E96, 2004
Shibasaki, T., Koyama, A., Hishida, A., Muso, E., Osawa, G., Yamabe, H., Shiiki, H., Makino, F., Sato, H., Ishikawa, I., Maeda, K., Tomita, K., Arakawa, M., Ishida, M., Sato, M., Nagase, M., Kashihara, N., Yorioka, N., Koike, T., Saito, T., Harada, T., Mitarai, T., Sugisaki, T., Nagasawa, T., Tomino, Y., Nojima, Y., Kobayashi, Y., and Sakai, O.
A randomized open-label comparative study of conventional therapy versus mizoribine onlaytherapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)
Clin. Exp. Nephrol., 8: 117-126, 2004
Inoue, H., Jackson, S.D., Vikulina, T., Klein, J.D., Tomita, K., and Bagnasco, S.M.
Identification and characterization of a Kidd antigen/UT-B urea transporter expressed in human colon
Am. J. Physiol. Cell. Physiol., 287: C30-C35. 2004
Miyamoto, K., Kitamoto, Y., Tokunaga, H., Takeya, M., Ezaki, T., Imamura, T., and Tomita, K.
Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat
Lab. Invest., 84: 1126-1136, 2004
Kitamoto, Y., Tomita, K., and Imamura, T.
Assessment of thrombin in the urine of glomerulonephritic patients by enzyme-linked immunosorbent assay
Ann. Clin. Biochem., 41: 133-7, 2004
Anzai, N., Miyazaki, H., Noshiro, R., Khamdang, S., Chairoungdua, A., Shin, H.J., Enomoto, A., Sakamoto, S., Hirata, T., Tomita, K., Kanai, Y., and Endou, H.
The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C-terminal
J. Biol. Chem., 279: 45942-45950, 2004
Tanaka, M., Fujiyama, S., Tanaka, M., Itoh, K., Matsushita, K., Matsushita, K., Matsuyama, K., Kakuda, H., and Tomita, K.
Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients
Ther. Apher. Dial., 8: 328-34, 2004
Nonoguchi, H., Inoue, T., Mori, T., Nakayama, Y., Kohda, Y., and Tomita, K.
Regulation of aquaporin-2 by metabolic acidosis
Am. J. Physiol. Cell. Physiol., 287: C814-C815, 2004
Ikebe, M., Nonoguchi, H., Nakayama, Y., Tashima, Y., Shimada, K., Tanzawa, K., and Tomita, K.
Regulation of endothelin-converting enzyme 1 in nephrotic syndrome in rats
Nephron. Exp. Nephrol., 94: e137-45, 2003
Jinnouchi, K., Terasaki, Y., Fujiyama, S., Tomita, K., Kuziel, W.A., Maeda, N., Takahashi, K., and Takeya, M.
Impaired hepatic granuloma formation in mice deficient in C-C chemokin receptor 2
J.Pathol., 200: 406-416, 2003
Okumura, Y., Nishikawa, M., Cui, P., Shiota, M., Nakamura, Y., Adachi, M., Kitamura, K., Tomita, K., and Kido, H.
Cloning and characterization of a transmembrane-type serine protease from rat kidney, a new member among the sodium channel activators
Biol. Chem., 384: 1483-1495, 2003
Tanaka, M., Itoh, K., Matsushita, K., Matsushita, K., Wakita, N., Adachi, M., Nonoguchi, H., Kitamura, K., Hosoyamada, M., Endou, H., and Tomita, K.
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF
Am. J. Kidney Dis., 42: 1287-92, 2003
Iwashita, K., Kitamura, K., Narikiyo, T., Adachi, M., Shiraishi, N., Miyoshi, T., Nagano, J., Tuyen, D.G., Nonoguchi, H., and Tomita, K.
Inhibition of prostasin expression by serine protease inhibitors in the kidney
J. Am. Soc. Nephrol., 14: 11-16, 2003
Shiraishi, N., Kitamura, K., Kohda, Y., Narikiyo, T., Adachi, M., Miyoshi, T., Iwashita, K., Nonoguchi, H., Miller, R.T., and Tomita, K.
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Kidney. Int., 63: 845-852, 2003
Nonoguchi, H., Kiyama, S., Inoue, H., Nakayama, Y., Inoue, T., Kohda, Y., Machida, K., Tajima, A., Kitamura, K., Miyoshi, T., Shimada, H., Shimada, H., Tajiri, M., Honda, Y., Tanaka, M., and Tomita, K.
Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism
Clin. Nephrol., 60: 225-232, 2003
Fujiyama, S., Shibata, J., Maeda, S., Tanaka, M., Noumaru, S., Sato, K., and Tomita, K.
Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol
Br. J. Cancer., 89: 1614-1619, 2003
Maeda, S., Shibata, J., Fujiyama, S., Tanaka, T., Noumaru, S., Sato, K., and Tomita, K.
Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma
Hepatogastroenterology, 50: 809-813, 2003
Fujiyama, S., Chikazawa, H., Honda, Y., and Tomita, K.
Effective interfelon therapy for chronic hepatitis C patients with low viral loads
Hepatogastroenterology, 50: 817-820, 2003
Fujimura, S., Kuwahara, K., Ezaki, T., Tomita, K., Hirose, S., and Sakaguchi, N.
Spontaneous increase of plasma-like cells with high GANP expression in the extrafollicular region of lymphoid organs of autoimmune-prone mice
J. Autoimmun., 20: 291-301, 2003
Imanishi, K., Nonoguchi, H., Nakayama, Y., Machida, K., Ikebe, M., and Tomita, K.
Type 1A angiotensin II receptor is regulated differently in proximal and distal nephron segments
Hypertens. Res. 26: 405-411, 2003
Machida, K., Nonoguchi, H., Wakamatsu, S., Inoue, H., Yosifovska, T., Inoue, T., and Tomita, K.
Acute regulation of the epithelial sodium channel gene by vasopressin and hyperosmolality
Hypertens. Res., 26: 629-34, 2003
Narikiyo T, Kitamura K, Adachi M, Miyoshi T, Iwashita K, Shiraishi N, Nonoguchi H, Chen LM, Chai KX, Chao J, Tomita K. Regulation of prostasin by aldosterone in the kidney. J Clin Invest. 109(3):401-8. 2002
Narikiyo, T., Kitamura, K., Adachi, M., Iwashita, K., Miyoshi, T., Shiraishi, N., Nonoguchi, H., Chen, L.M., Chai, K.X., Chao, J., and Tomita, K.
Regulation of Prostasin by Aldosterone in the Kidney
J. Clin. Invest., 109: 401-408, 2002
Yamakawa, K., Kitamura, K., Nonoguchi, H., Takasu, N., Miller, R.T., and Tomita, K.
Gα13 induces ppET-1 gene expression via JNK
Hypertens. Res., 25: 427-432, 2002
Kitamura, K. and Tomita, K.
Endothelin receptor antagonists prevent parathyroid cell proliferation caused by hypocalcemia in rats
Curr. Opin. Nephrol. Hy., 11: 411-416, 2002
Kurokawa, K., Abe, K., Saruta, T., Arakawa, M., Kikkawa, R., Ueda, N., Onoyama, K., Tomita, K., and Ogawa, N.
Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis
J. Renin. Angiotensin-Aldosterone. Syst., 3: 167-175, 2002
Kikuchi, Y., Nonoguchi, N., Machida, K., Wakamatsu, S., Koga, H., and Tomita, K.
Regulation of the apoptosis-related genes, Bax and Bcl-2, in the early stage of diabetes mellitus
Nephrology, 7: 294-302, 2002
Kitamoto, Y., Tokunaga, H., Miyamoto, K., and Tomita, K.
VEGF is an essential molecule for glomerular structuring
Nephrol. Dial. Transplant., 17 Suppl 9: 25-27, 2002
Maeda, S., Fujiyama, S., Tanaka, M., Ashihara, H., Hirata, R., and Tomita, K.
Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization
Hepatol Res., 23: 202-210, 2002
Fujiyama, S., Tanaka, M., Maeda, S., Ashihara, H., Hirata, R., and Tomita, K.
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma
Oncology, 62 Suppl 1: 57-63, 2002
Kanesaka, Y., Tokunaga, H., Iwashita, K., Fujimura, F., Naomi, S., and Tomita, K.
Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats
Endocrinology, 142: 407-413, 2001
Ikebe, M., Nonoguchi, H., Nakayama, Y., Tashima, Y., and Tomita, K.
Up-regulation of the secretory -type Na/K/2Cl cotransporter in the kidney by metabolic acidosis and dehydration in rats
J. Am. Soc. Nephrol., 12: 423-430, 2001
Tashima, Y., Kohda, Y., Nonoguchi, H., Ikebe, M., Machida K., Star, R.A., and Tomita, K.
Intranephron localization and regulation of the V1a vasopressin receptor during chronic metabolic acidosis and dehydration in rats
Pflugers. Arch., 442: 652-661, 2001
Inoue, T., Nonoguchi, H., and Tomita, K.
The physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct
Cardiovasc. Res., 51: 470-480, 2001
Kitamoto, Y., Matsuo, K., and Tomita, K.
Different response of urinary excretion of VEGF in patients with chronic and acute renal failure
Kidney. Int., 59: 385-386, 2001
Goto, J., Nishimura, S., Esumi, M., Makizumi, K., Rikihisa, T., Nishihara, T., Mizuno, K., Zhou, Y., Shikata, T., Fujiyama, S., and Tomita, K.
Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1
Hepatol. Res., 19: 270-283, 2001
Nagahama H., Hatakeyama, S., Nakayama, K., Nagata, M., Tomita, K., and Nakayama, K.
Spacial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27kip1 and p57kip2 during mouse development
Anat. Embryol., 203: 77-87, 2001
Kitamoto, Y., Takeya, M., Tokunaga, H., and Tomita, K.
Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney
Tohoku. J. Exp. Med., 195: 43-54, 2001
Adachi, M., Kitamura, K., Miyoshi, T., Narikiyo, T., Iwashita, K., Shiraishi, N., Nonoguchi, H., and Tomita, K.
Activation of Epithelial Sodium Channels by Prostasin in Xenopus Oocytes
J. Am. Soc. Nephrol. 12: 1114-1121, 2001
Kyuma, M., Ura, N., Torii, T., Takeuchi, H., Takizawa, H., Kitamura, K., Tomita, K., Sasaki, S., and Shimamoto, K.
A family with liddle's syndrome caused by a mutation in the beta subunit of the epithelial sodium channel
Clin. Exp. Hypertens. 23: 471-478, 2001
Handlogten, M.E., Huang, C., Shiraishi, N., Awata, H., and Miller, R.T.
The Ca2+-sensing receptor activates cytosolic phospholipase A2 via a Gqalpha -dependent ERK-independent pathway
J. Biol. Chem., 276: 13941-13948, 2001
Nakayama, Y., Naruse, M., Karakashian, A., Peng, T., Sands, JM., and Bagnasco, S.M.
Cloning of the rat Slc14a2 gene and genomic organization of the UT-A urea transporter
Biochim. Biophys. Acta., 1518: 19-26, 2001
Tabuchi, S., Gotoh, T., Miyanaka, K., Tomita, K., and Mori, M.
Regulation of genes for inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock
Biochem. Biophys. Res. Commun., 268: 221-224, 2000
Kikuchi, Y., Koga, H., Yasutomo, Y., Kawabata, Y., Shimizu, E., Naruse, M., Kiyama, S., Nonoguchi, H., Tomita, K., Sasatomi, Y., and Takebayashi, S.
Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction
Clin. Nephrol., 53: 467-472, 2000
Iwase, K., Miyanaka, K., Shimizu, A., Nagasaki, A., Gotoh, T., Mori, M., and Takiguchi, M.
Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment
J. Biol. Chem., 275: 11929-11933, 2000
Koshiyama, Y., Gotoh, T., Miyanaka, K., Kobayashi, T., Negi, A., and Mori, M.
Expression and localization of enzymes of arginine metabolism in the rat eye
Curr. Eye. Res., 20: 313-21, 2000
Ohki, G., Miyoshi, T., Murata, M., Ishibashi, K., Imai, M., and Suzuki, M.
A calcium-activated cation current by an alternatively spliced form of Trp3 in the heart
J. Biol. Chem., 275: 39055-60, 2000
Handlogten, M.E., Shiraishi, N., Awata, H., Huang, C., and Miller, R.T.
Extracellular Ca(2+)-sensing receptor is a promiscuous divalent cation sensor that responds to lead
Am. J. Physiol. Renal. Physiol., 279: F1083-F1091, 2000
Bagnasco, S.M., Peng, T., Nakayama, Y., and Sands, J.M.
Differential expression of individual UT-A urea transporter isoforms in rat kidney
J. Am. Soc. Nephrol., 11: 1980-1986, 2000
Nakayama, Y., Peng, T., Sands, JM., Bagnasco, S.M.
The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression
J. Biol. Chem., 275: 38275-38280, 2000
Tomita, K.
Nephrogenic diabetes insipidus: The era of gene therapy
Int. Med., 38: 755-756, 1999
Ito K., Okamoto, I., Araki, N., Kawano, Y., Nakao, M., Fujiyama, S., Tomita, K., Mimori, T., and Saya, H.
Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts
Oncogene, 18: 7080-7090, 1999
Miyoshi, T., Ooki, G., Murata, M., Hayakawa, H., Tomita, K., Imai, M., and Suzuki, M.
Expression of an mNSC1 in mammalian cells
Biochem. Biophys. Res. Commun., 265: 13-17, 1999
Nakayama, Y., Nonoguchi, H., Kiyama, S., Ikebe, M., Tashima, Y., Shimada, K., Tanzawa, K., and Tomita, K.
Intranephron distribution and regulation of endothelin converting enzyme - 1 in cyclosporine A - induced acute renal failure in rats
J. Am. Soc. Nephrol., 10: 562-571, 1999
Murakami, M., Tokutomi, N., Tokutomi, Y.,Tomita, K., and Nishi, K.
Alkalinization-induced K current of the mouse megakaryocyte
Jpn. J. Pharmacol., 79: 343-350, 1999
Ozaki, M., Gotoh, T., Nagasaki, A., Miyanaka, K., Takeya, M., Fujiyama, S., Tomita, K., and Mori, M.
Expression of arginase II and related enzymes in the rat small intestine and kidney
J. Biochem. 125: 586-593, 1999
Takayama, M., Nonoguchi, H., Yang, T., Machida, K., Terada, Y., Owada, A., Tomita, K., and Marumo, F.
Acute and chronic effects of hyperosmolality on mRNA and protein expression and the activity of Na-K-ATPase in the IMCD
Exp. Nephrol., 7: 295-305, 1999
Itoh, K., Nonoguchi, H., Shiraishi, N., and Tomita, K.
Gene regulation of atrial natriuretic peptide A, B, and C receptors in rat glomeruli
Exp. Nephrol., 7: 328-336, 1999
Kitamura, K., Shiraishi, N., Singer, W.D., Handlogten, M.E., Tomita, K., and Miller, R.T.
Endothelin-B receptors activate Gα13
Am. J. Physiol. (Cell Physiol.), 276: C930-C937, 1999
Inoue J., Iwaoka, T., Tokunaga, H., Takamune, K., Naomi, S., Araki, M., Takahama, K., Yamaguchi, K., and Tomita, K.
A family with Liddle’s syndrome caused by a new missense mutation in the βsubunit of the epithelial sodium channel
J. Clin. Endocrinol. Metab., 83: 2210-2213, 1998
Naomi, S., Iwaoka, T., Disashi, T., Inoue, J., Kanesaka, Y., Tokunaga, H., and Tomita, K.
Endothelin -1 inhibits endothelin converting enzyme-1 expression in cultured rat pulmonary endothelial cells
Circulation, 97: 234-236, 1998
Uehara, Y., Sasaguri, M., Kinoshita, A., Tsuji, E., Kiyose, H., Taniguchi, H., Noda, K., Ideishi, M., Inoue, J., Tomita, K., and Arakawa, K.
Genetic analysis of the epithelial sodium channel in Liddle’s syndrome
J. Hypertens., 16: 1131-1135, 1998
Miyanaka, K., Gotoh, T., Nagasaki, A., Takeya, M., Ozaki, M., Iwase, K., Takiguchi, M., Tomita, K., and Mori, M.
Immunohistological localization of arginase II and other enzymes of arginine metabolism in rat kidney and liver
Histochem. J., 30: 741-751, 1998
Kitamoto, Y., Imamura, T., Fukui, H., and Tomita, K.
Role of thrombin in mesangial proliferative glomerulonephritis
Kidney. Int., 54: 1767-1768, 1998
Nonoguchi, H., Owada, A., Umehara, I., Kiyama, S., Terada, Y., Marumo, F., and Tomita, K.
Renal effects of temocapril hydrochloride (CS-622) in patients with benign nephrosclerosis.
Nephrology, 4: 183-186, 1998
Nonoguchi, H., Itoh, K., Ikebe, M., and Tomita, K.
Regulation of the renal Na/K/2Clcotransporter gene: physiological modulation in health and abnormal function in disease
Exp. Nephrol., 6: 272-276, 1998
Suzuki, M., Murata, M., Ikeda, M., Miyoshi, T., and Imai, M.
Primary structure and functional expression of a novel non-selective cation channel
Biochem. Biophys. Res. Commun., 242: 191-196, 1998
Disashi, T., Nonoguchi, H., Iwaoka, T., Naomi, S., Nakayama, Y., Shimada, K., Tanzawa, K., and Tomita, K.
Endothelin converting enzyme-1 gene expression in the kidney of spontaneously hypertensive rats
Hypertension, 30: 1591-1597, 1998
Ikebe, M., Miyakawa, K., Takahashi, K., Ohbo, K., Nakamura, M., Sugamura, K., Suda, T., Yamamura, K., and Tomita, K.
Lympho-haematopoietic abnormalities and systemic lymphoproliferative disorder in interleukin-2 receptor chain-deficient mice
Int. J. Exp. Path., 78: 133-148, 1998
Shimada, T., Matsumura, K., Higashi, K., Higashi, K., Kimura, K., and Tomita, K.
Pulmonary fibrosis associated with polymyalgia rheumatica
Internal. Med., 36: 837-840, 1997
Owada, A., Nakao, M., Koike, J., Ujiie, K., Tomita, K., and Shiigai, T.
Effects of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized control study
Kidney. Int., 52: s188-s190, 1997
Nakayama, K., Takahashi, K.,. D. Shultz, LD., Miyakawa, K., and Tomita, K.
Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase
Int. J. Exp. Path., 78: 245-257, 1997
Fujiyama, S., Odoh, K., Tanaka, M., Kuramoto, I., and Tomita, K.
Evaluation of the timing of the booster injection after a primary vaccination against hepatitis
Am. J. Gastroenterol. Hepatol., 12: 172-175, 1997
Masuda, S., Saito, H., Nonoguchi, H., Tomita, K., and Inui, K.
mRNA distribution and membrane localization of the OAT-K1 organic anion transporter in rat renal tubules
FEBS Letters, 407: 127-131, 1997
Owada, A., Nonoguchi, H., Terada, Y., Marumo, F., and Tomita, K.
Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function
Clin. Exp. Hypertens., 19: 495-502, 1997
Terada, Y., Yamada, T., Nakashima, O., Sasaki, S., Nonoguchi, H., Tomita, K., and Marumo, F.
Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy
J. Am. Soc. Nephrol., 8: 817-819, 1997
Nonoguchi, H., Kiyama, S., Naruse, M., and Tomita, K.
Low-protein diet and progression of chronic renal failure
Lancet, 350: 146, 1997
Koike, J., Ujiie, K., Owada, A., Shiigai, T., Matui, N., Nonoguchi, H., Tomita, K., and Marumo, F.
Quasi-steadiness approximation for the two-compartment solute kinetic model
Kidney. Int., 52: 821-831, 1997
Owada, A., Nonoguchi, H., Terada, Y., Marumo, F., and Tomita, K.
Microlocalization and effects of adrenomedullin in microdissected nephron segments and in cultured mesangial cells of the rat
Am. J. Physiol., 272: F691-F697, 1997
Kitamoto Y., Tokunaga, H., and Tomita, K.
Vascular endothelial growth factor (VEGF) is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis
J. Clin. Invest., 99: 2351-2357, 1997
Kitamura, K., Tomita, K., and Miller, R.T.
Inhibition of NOS activity and NO-dependent Ca influx in renal epithelial cells by cAMP: Implications for cell injury
J. Am. Soc. Nephrol. 8: 558-568, 1997
Kitamura, K., Singer, W.D., Star, R.A., Muallem, S., and Miller, R.T.
Induction of inducible nitric-oxide synthase by the heterotrimeric G protein Gα13
J. Biol. Chem. 271: 7412-7415, 1996
Shimada T., Nishimura, Y., Kimura, G., Eto, S., and Tomita, K.
Vertebral osteomyelitis presenting with bilateral pleural effusions ina leprous patient
Diagn. Microbiol. Infect. Dis., 24: 101-103, 1996
Disashi T., Iwaoka, T., Inoue, J., Naomi, S., Fujimoto, Y., Umeda, T., and Tomita, K.
Magnesium metabolism in hyperthyroidism
Endocrine. J., 43: 397-402, 1996
Shudo, C., Masuda, Y., Sugita, H., Tamura, T., Furukawa, S., Hayashi, K., Hirata, H., Shikada, K., Tanaka, S., and Tomita, K.
Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats
Arzneim.-Forsch. Drug Res., 46(II), 852-854, 1996
Nonguchi, H., Takayama, M., Owada, A., Ujiie, K., Yamada, T., Nakashima, O., Sakuma, Y., Koike, J., Terada, Y., Marumo, F., and Tomita, K.
Role of urinary arginine vasopressin in the sodium excretion in patients with chronic renal failure
Am. J. Med. Sci., 312, 195-201, 1996
Khair-El-Din, T., Sicher, S.C., Vazquez, M.A., Chung, G.W., Stallworth, K.A., Kitamura, K., Miller, R.T., and Lu, C.Y.
Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils
J. Exp. Med. 183: 1241-1246, 1996
Kitamura, K., Xu, X., Lau, K.S., Muallem, S., and Miller, R.T.
Differential regulation of Ca2+ release-activated Ca2+ influx by heterotrimeric G proteions
J. Biol. Chem. 270: 29169-29175, 1995
Kugi, M., Kitamura, K., Cottam, G.L., and Miller, R.T.
Expression of Gαi2 mimics several aspects of LPS priming in a murine macrophage-like cell line
J. Inflamm. 45: 175-182, 1995
Kitamura, K., Singer, W.D., Cano, A., and Miller, R.T.
Gαq and Gα13 regulate NHE-1 and intracellular calcium in epithelial cells
Am. J. Physiol. (Cell Physiol.), 268: C101-C110, 1995
Yang, T., Terada, Y., Nonoguchi, H., Tomita, K., and Marumo, F.
Expression of mRNAs for different types of IP3 receptors in rat kidneys
Am. J. Physiol., 268: F1046-F1052, 1995
Terada, Y., Tomita, K., Homma, M., Nonoguchi, H., Yang, T., Yamada, T., Yuasa, Y., Krebs, E.G., and Marumo, F.
Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells
Kidney. Int., 48: 1801-1809, 1995
Shimada T., Higashi, K., Kimura, K., Shido, T., and Tomita, K.
Syndrome of inappropriate antidiuresis seen twice in eight years
Endocrine. J., 42: 163-169, 1995
Nonoguchi, H., Owada, A., Kobayashi, N., Takayama,M., Terada, Y., Koike, J., Ujiie, K., Marumo, F., Sakai, T., and Tomita, K.
Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts
J. Clin. Invest., 96: 1768-1778, 1995
Shudo, C., Masuda, Y., Sugita, H., Tanaka, S., and Tomita, K.
Beneficial effect of efonidipine hydrochloride (NZ-105) on proteinuria in aged spontaneously hypertensive rats
Pharmaceut. Sciences, 1: 333-335, 1995
Yamada, T., Terada, Y., Homma, M.K., Nonoguchi, H., Sasaki, S., Yuasa, Y., Tomita, K., and Marumo, F.
AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells
Kidney. Int., 48: 745-752, 1995
Ozaki, M., Terada, K., Kanazawa, M., Fujiyama, S., Tomita, K., Mori, M.
Enzyme-linked immunosorbent assay of carbamoylphosphate synthetase 1: Plasma enzyme in rat experimental hepatitis and its clearance
Enzyme Protein, 48: 213-221, 1994-1995
Terada, Y., Yamada, T., Takayama, M., Nonoguchi, H., Sasaki, S., Tomita, K., and Marumo, F.
Presence and regulation of Raf-1-K (kinase), MAPK-K, MAP-K, and S6-K in rat nephron segments
J. Am. Soc. Nephrol., 6: 1565-1577, 1995
Kitamura, K., and Miller, R.T.
Hormonal regulation of calcium influx by the adenylyl cyclase system
J. Clin. Invest., 94: 328-336, 1994
